|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 Lung Station (Tufts), Tufts University Medical Services, Boston City Hospital, Boston, and The Department of Respiratory Diseases, St. Vincent Hospital, Worcester
2 Hematology Unit (Tufts), Tufts University Medical Services, Boston City Hospital, Boston, and The Department of Respiratory Diseases, St. Vincent Hospital, Worcester
Studies in chronic stable bronchial asthma revealed normal P50507.40; COLD controls exhibited significantly elevated P50507.40 and 2,3-DPG levels. In patients with acute asthma, no differences in P50507.40 or 2,3-DPG were discernible. Subdivision of acute asthma into categories with hyperventilation (PaCO2
37.0 mm Hg) and hypoventilation (PaCO2
37.1 mm Hg) revealed that hyperventilating patients exhibited a mean P50507.40 of 27.7 ± 4.3 mm Hg unchanged over normal controls or chronic stable asthma while hypoventilating subjects were significantly left-shifted (P50507.40 = 25.1 ± 0.7 mm Hg) contrasted with normal and stable asthmatic patients (P < 0.001) despite significant oxyhemoglobin desaturation (80.2 percent). 2,3-DPG data paralleled these observations. The pH was found to influence the P50 change in the hypoventilating population. MCHC measurements, percent HbCO or hemoglobin was not related. While the Bohr effect, reflected in estimates of physiologic in vivo P50 values, tends to temper leftward shifts in asthma associated with respiratory acidosis, the lack of compensatory increase in 2,3-DPG and an associated elevated P50507.40, in spite of the hypoxic stimulus, may limit maximal oxygen delivery to tissues.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |